These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5538764)

  • 1. Lactulose treatment of hepatic encephalopathy in outpatients.
    Brown H; Trey C; McDermott WV
    Arch Surg; 1971 Jan; 102(1):25-7. PubMed ID: 5538764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
    Eisenburg J; Krumpoch B; Grunst J; Weinzierl M; Munte A; Schmidt S; Magerl W; Schauer S
    Fortschr Med; 1972 Aug; 90(24):837-48. PubMed ID: 4639347
    [No Abstract]   [Full Text] [Related]  

  • 3. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 4. Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.
    Rorsman G; Sulg I
    Acta Med Scand; 1970 May; 187(5):337-46. PubMed ID: 5526951
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactulose treatment of hepatic encephalopathy: effects on carbohydrate metabolism and colonic hydrogen ion concentration.
    Trey C; Brown H; Goransky L; McDermott WV
    Surg Forum; 1970; 21():355-6. PubMed ID: 4936990
    [No Abstract]   [Full Text] [Related]  

  • 6. Encephalopathy after portacaval shunting managed with lactulose.
    Brown H; Trey C; McDermott WV
    Am J Surg; 1970 Feb; 119(2):132-7. PubMed ID: 5440784
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acidophilus milk in dietary treatment of liver cirrhosis with encephalopathy].
    Abrahamsson L; Bengtsson S; Hambraeus L; Ulwán O; Oberg G
    Nord Med; 1971 Aug; 86(33):969-73. PubMed ID: 4999372
    [No Abstract]   [Full Text] [Related]  

  • 8. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 9. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon.
    Bircher J; Haemmerli UP; Trabert E; Largiader F; Mocetti T
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):352-7. PubMed ID: 5564547
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)].
    Cassi E; Sala E; Beretta R; Colombo A; Cova L; Ezechieli S; Malacco E; Massarotti G; Pagani C
    Clin Ter; 1972 Dec; 63(6):531-56. PubMed ID: 4656204
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
    Bircher J; Haemmerli UP; Williams R
    Gastroenterology; 1970 Apr; 58(4):595-7. PubMed ID: 5438009
    [No Abstract]   [Full Text] [Related]  

  • 13. Subtotal portacaval shunt obliteration for chronic hepatic encephalopathy.
    Kakos GS; Evans WE; Czuba M; Spiegel J; Greenberger NJ
    Ann Surg; 1973 Mar; 177(3):276-9. PubMed ID: 4692114
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term treatment of portal-systemic encephalopathy with lactulose.
    Ma MH; McLeod JG; Blackburn CR
    Australas Ann Med; 1969 May; 18(2):117-23. PubMed ID: 5793699
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic encephalopathy evaluation.
    Delgado RL
    Lab Res Methods Biol Med; 1983; 7():587-601. PubMed ID: 6353114
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic portal-systemic encephalopathy with lactulose.
    Bircher J; Müller J; Guggenheim P; Haemmerli UP
    Lancet; 1966 Apr; 1(7443):890-2. PubMed ID: 4159616
    [No Abstract]   [Full Text] [Related]  

  • 20. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.
    Rikkers L; Jenko P; Rudman D; Freides D
    Gastroenterology; 1978 Sep; 75(3):462-9. PubMed ID: 680502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.